ER
NUVA

Enlightenment Research’s NuVasive, Inc. NUVA Stock Holding History

Enlightenment Research’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-500
Closed -$25K – 726
2018
Q4 		$25K Buy
+500
New +$30.1K 0.03% 405

Other funds holding NUVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Enlightenment Research's NUVA Position: Q1 2019 in Review

Enlightenment Research sold out of NuVasive, Inc. (NUVA) in Q1 2019, closing a stake of 500 shares — an estimated $25K sold.

Enlightenment Research first reported a position in NUVA in Q4 2018 and held it in 1 quarter. The position peaked at $25K in Q4 2018. 255 funds tracked by Wall St. Rank hold NUVA as of Q1 2019.

  • Enlightenment Research reported no remaining NuVasive, Inc. position as of Q1 2019 after selling out during the quarter.
  • Enlightenment Research sold 500 NuVasive, Inc. shares in Q1 2019, an estimated $25K.
  • Enlightenment Research first reported a position in NuVasive, Inc. in Q4 2018 and held it in 1 quarter.
  • Enlightenment Research's NuVasive, Inc. position peaked at $25K in Q4 2018.
  • 255 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2019.

Based on Enlightenment Research's 13F filing for Q1 2019, filed 3 May 2019.